Welcome to LookChem.com Sign In|Join Free
  • or
C13H15N5O3 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1361949-75-8

Post Buying Request

1361949-75-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1361949-75-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1361949-75-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,1,9,4 and 9 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1361949-75:
(9*1)+(8*3)+(7*6)+(6*1)+(5*9)+(4*4)+(3*9)+(2*7)+(1*5)=188
188 % 10 = 8
So 1361949-75-8 is a valid CAS Registry Number.

1361949-75-8Downstream Products

1361949-75-8Relevant academic research and scientific papers

Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives

Hernández, Paola,Cabrera, Mauricio,Lavaggi, María Laura,Celano, Laura,Tiscornia, Inés,Rodrigues Da Costa, Thiago,Thomson, Leonor,Bollati-Fogolín, Mariela,Miranda, Ana Luisa P.,Lima, Lidia M.,Barreiro, Eliezer J.,González, Mercedes,Cerecetto, Hugo

experimental part, p. 2158 - 2171 (2012/05/04)

We report the design, the synthesis and the biological evaluation of the analgesic and anti-inflammatory activities of furoxanyl N-acylhydrazones (furoxanyl-NAH) by applying molecular hybridization approach. Hybrid compounds with IL-8-release inhibition capabilities were identified. Among them, furoxanyl-NAH, 17, and benzofuroxanyl-derivative, 24, together with furoxanyl-NAH derivative, 31, without IL-8 inhibition displayed both orally analgesic and anti-inflammatory activities. These hybrid derivatives do not have additional LOX- or COX-inhibition activities. For instance, LOX-inhibition by furoxanyl-NAH derivative, 42, emerged as a structural lead to develop new inhibitors. The lack of mutagenicity of the active derivatives 17, 31, and 42, allow us to propose them as candidates for further clinical studies. These results confirmed the success in the exploitation of hybridization strategy for identification of novel N-acylhydrazones (NAH) with optimized activities.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1361949-75-8